Long Focus Capital Management LLC lifted its stake in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 130.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 744,748 shares of the company's stock after purchasing an additional 421,931 shares during the period. Long Focus Capital Management LLC owned 1.19% of Bioceres Crop Solutions worth $4,528,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Jump Financial LLC bought a new stake in Bioceres Crop Solutions during the fourth quarter worth $72,000. Ping Capital Management Inc. raised its holdings in shares of Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after purchasing an additional 3,000 shares during the period. Stifel Financial Corp lifted its stake in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Bioceres Crop Solutions by 17.0% during the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock worth $640,000 after purchasing an additional 15,328 shares during the period. Finally, Ballast Asset Management LP increased its position in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock worth $2,620,000 after buying an additional 82,187 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company's stock.
Bioceres Crop Solutions Stock Performance
NASDAQ BIOX traded down $0.09 on Monday, reaching $4.22. The stock had a trading volume of 21,610 shares, compared to its average volume of 167,732. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96. The company has a market cap of $264.33 million, a P/E ratio of 210.86 and a beta of 0.60. The firm has a fifty day moving average of $4.39 and a two-hundred day moving average of $5.82. Bioceres Crop Solutions Corp. has a 1-year low of $3.51 and a 1-year high of $13.18.
Wall Street Analyst Weigh In
BIOX has been the subject of several research analyst reports. Lake Street Capital reduced their target price on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Oppenheimer reduced their price objective on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research report on Tuesday, April 22nd. Finally, Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $8.63.
Get Our Latest Report on Bioceres Crop Solutions
Bioceres Crop Solutions Company Profile
(
Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Stories

Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.